IMPERIAL CLEVITE INC. – Trademark Portfolio
Entity Type: 03
IMPERIAL CLEVITE INC. owns a portfolio of 25 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as "IMP", KWIK-TITE, and CONFORMA CLAD. Of these, 3 are registered. The portfolio spans 7 Nice Classification classes, led by Class 7 (Machinery) and Class 8 (Hand Tools). Headquartered in GLENVIEW, IL.
1275 MILWAUKEE AVE., SUITE 300
GLENVIEW, IL 60025
Showing of trademarks Trademarks
Trademark Classifications
IMPERIAL CLEVITE INC.'s trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Machines and machine tools; motors and engines; machine coupling and transmission components
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Common metals and their alloys; metal building materials; transportable buildings of metal
Frequently Asked Questions
How many trademarks does IMPERIAL CLEVITE INC. have?
IMPERIAL CLEVITE INC. has 25 U.S. trademarks filed with the USPTO. Of these, 3 registered, 22 cancelled.
What trademark classes does IMPERIAL CLEVITE INC. file in?
IMPERIAL CLEVITE INC. files trademarks across 7 Nice Classification classes. The most active classes are Class 7 (Machinery), Class 8 (Hand Tools), Class 9 (Computers & Electronics), Class 6 (Metal Goods), Class 17 (Rubber Goods). Class 7 covers machines and machine tools; motors and engines; machine coupling and transmission components.
What are IMPERIAL CLEVITE INC.'s most well-known trademarks?
IMPERIAL CLEVITE INC.'s registered trademark portfolio includes well-known marks such as "IMP", KWIK-TITE, and CONFORMA CLAD. These are among 3 currently registered trademarks in the portfolio.
What is IMPERIAL CLEVITE INC.'s trademark registration success rate?
IMPERIAL CLEVITE INC. has a 12% trademark registration rate, with 3 out of 25 resolved applications resulting in successful registration. Currently, 0 applications are pending review.